Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
Location: Sweden
Total raised: $46M
Investors 1
| Date | Name | Website |
| 29.12.2024 | ARCH Ventu... | archventur... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.04.2026 | - | $20M | ARCH Ventu... |
| 11.06.2024 | Series A | $26M | - |
Mentions in press and media 5
| Date | Title | Description |
| 30.04.2026 | Moleculent: $20 Million Raised To Scale Functional Profiling Platform For Cell-Cell Communication Research | Moleculent, a Stockholm-based life sciences technology company pioneering functional profiling to map cell-cell communication at scale in human tissue, has closed a $20 million financing round led by Rubicon Healthcare Partners, with partic... |
| 28.05.2025 | Genetic Analysis AS: Navigating Challenges and Opportunities in the Microbiome Market | In the world of biotechnology, few companies have captured the imagination quite like Genetic Analysis AS (GA). This Oslo-based firm is at the forefront of microbiome diagnostics, a field that promises to revolutionize healthcare. As the co... |
| 27.05.2025 | Publication of Q1 report January – March 2025 | Publication of Q1 report January – March 2025 Tue, May 27, 2025 08:00 CET Report this content OSLO, NORWAY – May 27 2025: Genetic Analysis AS ("GA" or the "Company") hereby publishes the interim report for the period Jan... |
| 11.06.2024 | Moleculent Raises $26M in Series A Financing | Moleculent, a Stockholm, Sweden-based provider a functional biology platform, raised $26M in Series A funding. The round was co-led by ARCH Venture Partners and Eir Ventures with participation from existing investors. The company intends to... |
| - | Moleculent | “Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.” |